The deconfinement phase transition in the Hamiltonian approach to Yang--Mills theory in Coulomb gauge

The deconfinement phase transition of SU(2) Yang--Mills theory is investigated in the Hamiltonian approach in Coulomb gauge assuming a quasi-particle picture for the grand canonical gluon ensemble. The thermal equilibrium state is found by minimizing the free energy with respect to the quasi-gluon energy. Above the deconfinement phase transition the ghost form factor remains infrared divergent but its infrared exponent is approximately halved, while the gluon energy, being infrared divergent in the confined phase, becomes infrared finite in the deconfined phase. For the effective gluon mass we find a critical exponent of 0.37. Using the lattice results for the gluon propagator to fix the scale, the deconfinement transition temperature is obtained in the range of 275 to 290 MeV.Comment: 20 pages, 13 figures, accepted for publication by Phys. Rev.

Towards the 3D-Imaging of Sources

Geometric details of a nuclear reaction zone, at the time of particle emission, can be restored from low relative-velocity particle-correlations, following imaging. Some of the source details get erased and are a potential cause of problems in the imaging, in the form of instabilities. These can be coped with by following the method of discretized optimization for the restored sources. So far it has been possible to produce 1-dimensional emission source images, corresponding to the reactions averaged over all possible spatial directions. Currently, efforts are in progress to restore angular details.Comment: Talk given at the Int. Workshop on Hot and Dense Matter in Relativistic Heavy Ion Collisions, March 24-27, 2004, Budapest; 10 pages, 6 figure

METSAT: Advanced Microwave Sounding Unit-A1 (AMSU-A1). Structural Mathematical Model

This is the Meteorological Satellite (METSAT) Structural Mathematical Model for the Integrated Advanced Microwave Sounding Unit-A (AMSU-A), A1

AC Hopping Magnetotransport Across the Spin Flop Transition in Lightly Doped La_2CuO_4

The weak ferromagnetism present in insulating La_{2}CuO_4 at low doping leads to a spin flop transition, and to transverse (interplane) hopping of holes in a strong external magnetic field. This results in a dimensional crossover 2D $\to$ 3D for the in-plane transport, which in turn leads to an increase of the hole's localization length and increased conduction. We demonstrate theoretically that as a consequence of this mechanism, a frequency-dependent jump of the in-plane ac hopping conductivity occurs at the spin flop transition. We predict the value and the frequency dependence of the jump. Experimental studies of this effect would provide important confirmation of the emerging understanding of lightly doped insulating La_{2-x}Sr_xCuO_4.Comment: 4 pages, 1 figur

Pressure and linear heat capacity in the superconducting state of thoriated UBe13

Even well below Tc, the heavy-fermion superconductor (U,Th)Be13 has a large linear term in its specific heat. We show that under uniaxial pressure, the linear heat capacity increases in magnitude by more than a factor of two. The change is reversible and suggests that the linear term is an intrinsic property of the material. In addition, we find no evidence of hysteresis or of latent heat in the low-temperature and low-pressure portion of the phase diagram, showing that all transitions in this region are second order.Comment: 5 pages, 4 figure

Half-skyrmion picture of single hole doped CuO_2 plane

Based on the Zhang-Rice singlet picture, it is argued that the half-skyrmion is created by the doped hole in the single hole doped high-T_c cuprates with N'eel ordering. The spin configuration around the Zhang-Rice singlet, which has the form of superposition of the two different d-orbital hole spin states, is studied within the non-linear \sigma model and the CP^1 model. The spin configurations associated with each hole spin state are obtained, and we find that the superposition of these spin configuration turns out to be the half-skyrmion that is characterized by a half of the topological charge. The excitation spectrum of the half-skyrmion is obtained by making use of Lorentz invariance of the effective theory and is qualitatively in good agreement with angle resolved photoemission spectroscopy on the parent compunds. Estimated values of the parameters contained in the excitation spectrum are in good agreement with experimentally obtained values. The half-skyrmion theory suggests a picture for the difference between the hole doped compounds and the electron doped compounds.Comment: 13 pages, 2 figures, to be published in Phys. Rev.

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial.

BackgroundSmoking rates are high in adults with anxiety disorders (ADs), yet little is known about the safety and efficacy of smoking-cessation pharmacotherapies in this group.MethodsPost hoc analyses in 712 smokers with AD (posttraumatic stress disorder [PTSD], n = 192; generalized anxiety disorder [GAD], n = 243; panic disorder [PD], n = 277) and in a nonpsychiatric cohort (NPC; n = 4,028). Participants were randomly assigned to varenicline, bupropion, nicotine-replacement therapy (NRT), or placebo plus weekly smoking-cessation counseling for 12 weeks, with 12 weeks follow-up. General linear models were used to test the effects of treatment group, cohort, and their interaction on neuropsychiatric adverse events (NPSAEs), and continuous abstinence weeks 9-12 (treatment) and 9-24 (follow-up).ResultsNPSAE incidence for PTSD (6.9%), GAD (5.4%), and PD (6.2%) was higher versus NPC (2.1%), regardless of treatment. Across all treatments, smokers with PTSD (odds ratio [OR] = 0.58), GAD (OR = 0.72), and PD (OR = 0.53) had lower continuous abstinence rates weeks 9-12 (CAR9-12) versus NPC. Varenicline demonstrated superior efficacy to placebo in smokers with GAD and PD, respectively (OR = 4.53; 95% confidence interval [CI] = 1.20-17.10; and OR = 8.49; 95% CI = 1.57-45.78); NRT was superior to placebo in smokers with PD (OR = 7.42; 95% CI = 1.37-40.35). While there was no statistically significant effect of any treatment on CAR9-12 for smokers with PTSD, varenicline improved 7-day point prevalence abstinence at end of treatment in this subcohort.ConclusionIndividuals with ADs were more likely than those without psychiatric illness to experience moderate to severe NPSAEs during smoking-cessation attempts, regardless of treatment. While the study was not powered to evaluate abstinence outcomes with these subgroups of smokers with ADs, varenicline provided significant benefit for cessation in those with GAD and PD, while NRT provided significant benefit for those with PD